market

The next big wave of patent cliffs is ahead; expect biopharma M&A to rise – report


Intellectual Property Rights, Copyright, Patent or Trademark Infringement

Olivier Le Moal

With a significant number of blockbuster drugs at risk of losing market exclusivities in the next five years, big pharma is expected to ramp up deal-making and market consolidation in the short-to-medium-term, the credit rating and research house, Fitch

Readers Also Like:  IMF warns oil price surge sparked by Middle East war could hobble global recovery
Readers Also Like:  What is Khaki Finance? Investing Explained



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.